| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 687330 | Adenosine, 2'-amino-2'-deoxy-3',5'- O-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]- (9CI) | 0.0141370771633662 | 0.23404868 |
| NSC 696990 | Null | 0.0141370771633662 | 0.1064941 |
| NSC 702338 | 4-Thiazolidinone, 3-(4-chlorophenyl)-2-(3,4,5-trimethoxyphenyl)- | 0.0141370771633662 | 0.19574198 |
| NSC 703467 | Null | 0.0141370771633662 | 0.19171647 |
| NSC 711745 | Null | 0.0141370771633662 | 0.2389518 |
| NSC 722341 | 2-(3'-Hydroxy-3'-methylbut-1'-ynyl)-4,6-di-(4''-methoxypheno xy)-1,3,5-triazine | 0.0141370771633662 | 0.17802395 |
| NSC 725191 | 1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol | 0.0141370771633662 | 0.25774336 |
| NSC 747452 | 3,19-(4-Acetamido)benzylidineandrographolide | 0.0141370771633662 | 0.31465619 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0141370771633662 | 0.34304528 |
| NSC 79563 | 1,3-bis(4-chlorobenzyl)-2-(phenanthren-9-yl)hexahydropyrimidine | 0.0141370771633662 | -0.091730245 |